Related references
Note: Only part of the references are listed.Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Joan-En Chang-Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Randomized Controlled Trial of an Intravitreous Dexamethasone Drug Delivery System in Patients With Diabetic Macular Edema
Julia A. Haller et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Management of Macular Edema from Retinal Vein Occlusions: You Can Never Have Too Many Choices
Neil M. Bressler et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
David M. Brown et al.
OPHTHALMOLOGY (2010)
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2010)
Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome
George A. Williams et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion
ARCHIVES OF OPHTHALMOLOGY (2009)
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
ARCHIVES OF OPHTHALMOLOGY (2009)
In vitro benzyl alcohol cytotoxicity: Implications for intravitreal use of triamcinolone acetonide
Yi-Sheng Chang et al.
EXPERIMENTAL EYE RESEARCH (2008)
Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye
Bernd A. Kamppeter et al.
OPHTHALMOLOGY (2008)
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
Pharmacokinetics of intravitreal ranibizumab (Lucentis)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes
Ates Yanyali et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells
Yi-Sheng Chang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection
Michael D. Ober et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
The use of intravitreal corticosteroids, evidence-based and otherwise
Stephen M. Conti et al.
CURRENT OPINION IN OPHTHALMOLOGY (2006)
Retinal toxicity of intravitreal triamcinolone acetonide
Seung-Young Yu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Cell viability effects of triamcinolone acetonide and preservative vehicle formulations
S Shaikh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells
R Narayanan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: A randomized clinical trial
MA Bonini et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment
F Patelli et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Comparison of intravitreal versus posterior sub-tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema
JA Cardillo et al.
OPHTHALMOLOGY (2005)
Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema
H Ozdemir et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes
HS Chin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema
A Yanyali et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone
J Larsson et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Complications of intravitreal injection of triamcinolone acetonide
A Özkiris et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2005)
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown
JL Edelman et al.
EXPERIMENTAL EYE RESEARCH (2005)
Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema
AA Moshfeghi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: Comparison with dexamethasone and hydrocortisone
CK Yeung et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2004)
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection
DB Roth et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection
PM Beer et al.
OPHTHALMOLOGY (2003)
Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate
O Weijtens et al.
OPHTHALMOLOGY (2002)
Corticosteroids in ophthalmology: Past-present-future
Z Sherif et al.
OPHTHALMOLOGICA (2002)
Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin
DA Antonetti et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose
O Weijtens et al.
OPHTHALMOLOGY (2000)
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration
PL Penfold et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
